| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/01/2004 | EP1451314A2 Novel isoamylases and associated methods and products |
| 09/01/2004 | EP1451313A2 Method for cloning and expression of bseri restriction endonuclease and bseri methylase in e. coli |
| 09/01/2004 | EP1451312A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/01/2004 | EP1451307A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/01/2004 | EP1451305A2 Epitope synchronization in antigen presenting cells |
| 09/01/2004 | EP1451303A1 Detection of haematopoietic stem cells and progeny and uses thereof |
| 09/01/2004 | EP1451301A2 Promotion of somatic embryogenesis in plants by wuschel gene expression |
| 09/01/2004 | EP1451297A1 Phenotypic screen of chimeric proteins |
| 09/01/2004 | EP1451296A2 Expression of polypeptides in rod outer segment membranes |
| 09/01/2004 | EP1451295A2 Methods for mutating genes in cells and animals using insertional mutagenesis |
| 09/01/2004 | EP1451293A2 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 09/01/2004 | EP1451292A1 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted |
| 09/01/2004 | EP1451291A2 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells |
| 09/01/2004 | EP1451226A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation |
| 09/01/2004 | EP1451223A2 Expression control using variable intergenic sequences |
| 09/01/2004 | EP1451222A2 Novel proteins with il-6 inhibiting activity |
| 09/01/2004 | EP1451221A2 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN |
| 09/01/2004 | EP1451219A1 Nuclear protein "shoca" - a component of the wnt signalling pathway |
| 09/01/2004 | EP1451218A2 Methods for the treatment and prognosis of leukemia and other cancer types |
| 09/01/2004 | EP1451217A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides |
| 09/01/2004 | EP1451215A2 Method to isolate genes involved in aging |
| 09/01/2004 | EP1451214A2 Protein-protein interactions in human immunodeficiency virus |
| 09/01/2004 | EP1451213A2 Human and murine cytokine polypeptides |
| 09/01/2004 | EP1451212A2 Structural and cytoskeleton-associated proteins |
| 09/01/2004 | EP1451205A2 Antisense therapy using oligonucleotides that target human kinesin genes for treatment of cancer |
| 09/01/2004 | EP1451201A2 Nucleotide analogues and their use for nucleic acid sequencing |
| 09/01/2004 | EP1451155A1 Compositions, methods and kits pertaining to luminescent compounds |
| 09/01/2004 | EP1450960A1 Apparatus and method for modification of magnetically immobilized biomolecules |
| 09/01/2004 | EP1450862A1 Replication competent dual-ad vectors for vaccine and immunotherapy applications |
| 09/01/2004 | EP1450854A2 Vaccine |
| 09/01/2004 | EP1450847A2 Apo2 ligand/trail formulations |
| 09/01/2004 | EP1450846A2 Self-assembling polymers, and materials fabricated therefrom |
| 09/01/2004 | EP1450837A2 Interleukin-1 receptors in the treatment of diseases |
| 09/01/2004 | EP1450828A2 In situ immunization |
| 09/01/2004 | EP1450778A2 Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases |
| 09/01/2004 | EP1450752A2 Multivalent streptococcal vaccine compositions and methods for use |
| 09/01/2004 | EP1450751A2 Nanoparticle delivery vehicle |
| 09/01/2004 | EP1450666A2 Methods and compositions to treat cardiovascular disease using 139,258,1261,1486,2398,2414,7660,8587,10183,10550,12680,17921,32248,60489 or 93804 |
| 09/01/2004 | EP1450602A2 Identifying and characterizing genes |
| 09/01/2004 | EP1368367A4 Polynucleotide constructs for increased lysine production |
| 09/01/2004 | EP1303534A4 Promyostatin peptides and methods of using same |
| 09/01/2004 | EP1237541B1 Liposomes comprising a complex of a polyanionic compound and calcium phosphate |
| 09/01/2004 | EP1203094B1 Method for marking solid, liquid and gaseous substances |
| 09/01/2004 | EP1185670B1 Method of increasing the content of fatty acids in plant seeds |
| 09/01/2004 | EP1165135B1 Methods of screening for compounds modulating fxr receptors |
| 09/01/2004 | EP1156107B1 Method for analyzing gene expression frequency |
| 09/01/2004 | EP1117303A4 Vegetable oil having elevated stearic acid content |
| 09/01/2004 | EP1089764B1 Stimulating the immune system |
| 09/01/2004 | EP1042482B1 Acetyl-coa-carboxylase from candida albicans |
| 09/01/2004 | EP0979306A4 An assay for the measurement of dna synthesis rates |
| 09/01/2004 | EP0975764B1 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin |
| 09/01/2004 | EP0973908B1 Plants with controlled side-shoot formation and/or controlled abscission area formation |
| 09/01/2004 | EP0941369B1 Dna for evaluating the progression potential of cervical lesions |
| 09/01/2004 | EP0937139B1 Amidase |
| 09/01/2004 | EP0772627B1 Production of biologically active recombinant neurotrophic protein |
| 09/01/2004 | EP0769057B1 RECOMBINANT MONO AND POLY ANTIGENS TO DETECT CYTOMEGALOVIRUS-SPECIFIC IgM IN HUMAN SERA BY ENZYME IMMUNOASSAY |
| 09/01/2004 | EP0764172B1 Synthetic peptide analogs of lung surfactant protein sp-c |
| 09/01/2004 | EP0728141B1 A method for identifying anti-parasitic compounds |
| 09/01/2004 | EP0700442B1 Immortalized human cell lines containing exogenous cytochrome p450 genes |
| 09/01/2004 | EP0634936B1 Methods for immunocontraception |
| 09/01/2004 | EP0616640B1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 09/01/2004 | EP0610254B1 Glial derived neurotrophic factor |
| 09/01/2004 | CN1526111A Polymorphic marker that can be used to assess the efficacy of interferon therapy |
| 09/01/2004 | CN1526026A Analytical method and kit |
| 09/01/2004 | CN1526025A Genes expressed in breast cancer as prognostic and therapeutic targets |
| 09/01/2004 | CN1526022A Testing endosymbiont cellular organelles and compounds identifiable therewith |
| 09/01/2004 | CN1526021A Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 09/01/2004 | CN1526020A Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins. |
| 09/01/2004 | CN1526019A Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses |
| 09/01/2004 | CN1526018A Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/01/2004 | CN1526017A Gene associated with leishmania parasite virulence |
| 09/01/2004 | CN1526016A Method for stabilization of nucleic acids |
| 09/01/2004 | CN1526014A Paramyxovirus vectors for introducing foreign genes into skeletal muscle |
| 09/01/2004 | CN1526013A Lipolytic enzyme genes |
| 09/01/2004 | CN1526012A A specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it |
| 09/01/2004 | CN1526011A Inhibition of apoptosis process and improvement of cell performance |
| 09/01/2004 | CN1526010A Bacterial host strains |
| 09/01/2004 | CN1525981A T1R taste receptors and genes encoding same |
| 09/01/2004 | CN1525977A Purification of human serum albumin |
| 09/01/2004 | CN1525866A Treatment using neublastin polypeptides |
| 09/01/2004 | CN1525864A Mucin peptide with immunoenhancing properties |
| 09/01/2004 | CN1525814A Method for increasing glutamate content of plants and the plants having increased glutamate content |
| 09/01/2004 | CN1525168A Methods of detecting alzheimer's disease |
| 09/01/2004 | CN1524959A Method for producing gene engineering recombination 192 peptide human growth hormone |
| 09/01/2004 | CN1524958A Angiotensin II correlative gene, coding protein and application thereof |
| 09/01/2004 | CN1524957A Recombinant protein a gene ,its expression products and use |
| 09/01/2004 | CN1524956A Method for producing l-lysine |
| 09/01/2004 | CN1524955A Method for constructing transgene kelp |
| 09/01/2004 | CN1524952A False virosome vaccine with recombinant replicon of dengue fever virus as carrier |
| 09/01/2004 | CN1524951A Vaccine for human papiloma virus |
| 09/01/2004 | CN1524879A Anti endothelial cell element, genes encoding same and pharmaceutical uses thereof |
| 09/01/2004 | CN1524877A Construction and preparation of stroma cell derivative factor - 1ª‡ recombinant mutant |
| 09/01/2004 | CN1524876A Na+/h+ counter rotatable protein of salicornia europaeal , genes encoding same and use thereof |
| 09/01/2004 | CN1524874A E1A protein, its preparing process and combination of medicament comprising the protein |
| 09/01/2004 | CN1524583A Use of gene for expressing Notch-ligand in production of medicinal preparations for immunotherapy |
| 09/01/2004 | CN1524575A Virulence genes and proteins, and their use |
| 09/01/2004 | CN1164769C Method and device of testing nudein hybride pair on gene chip by four-dimensional paramerter |
| 09/01/2004 | CN1164760C Tenascin-C nucleic acid ligands |
| 09/01/2004 | CN1164757C Method for reproducing fly maggot with transgenic antibacterial peptide |
| 09/01/2004 | CN1164756C Nucleic acid transporter containing polypeptide and recombinant virus vector |